Shikonin exerts antitumor activity in Burkitt's lymphoma by inhibiting C-MYC and PI3K/AKT/mTOR pathway and acts synergistically with doxorubicin.
about
Shikonin exerts antitumor activity in Burkitt's lymphoma by inhibiting C-MYC and PI3K/AKT/mTOR pathway and acts synergistically with doxorubicin.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Shikonin exerts antitumor acti ...... ergistically with doxorubicin.
@en
Shikonin exerts antitumor acti ...... ergistically with doxorubicin.
@nl
type
label
Shikonin exerts antitumor acti ...... ergistically with doxorubicin.
@en
Shikonin exerts antitumor acti ...... ergistically with doxorubicin.
@nl
prefLabel
Shikonin exerts antitumor acti ...... ergistically with doxorubicin.
@en
Shikonin exerts antitumor acti ...... ergistically with doxorubicin.
@nl
P2093
P2860
P1433
P1476
Shikonin exerts antitumor acti ...... ergistically with doxorubicin.
@en
P2093
Wenbin Qian
Xianbo Huang
Xiangmin Tong
Zhenzhen Chen
P2860
P356
10.1038/S41598-018-21570-Z
P407
P577
2018-02-20T00:00:00Z